Q: How do you look at the nano-biotech achievements in India so far? Have the applications been enough?Dr Pachauri: I th...
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...
Singapore: Universal Biosensors reported its unaudited financial result for FY 2012 including a doubling of total revenu...
Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...
Singapore: Drug and diagnostic company Agenix announced that it was on track to submit a new drug clinical trial applic...
Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a lar...
Singapore: Prima BioMed's interim data from the CAN-003 phase II clinical trial of cancer vaccine therapy, CVac, which ...
Singapore: Starpharma reported net cash outflows from operating and investing activities for the year ending June 30, 20...
Singapore: South Australian biotechnology company, GeneWorks, developed a new DNA barcoding technology for use as a secu...
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...
Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met ...
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...
Singapore: A team of Australian scientists discovered new genes that show identifiable changes in the blood of people wi...
Singapore: Algae.Tec, an Australian biofuels company, has appointed Mr Colin McGregor as general manager project operati...
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...
Singapore: Irish medtech firm Mainstay Medical has started its clinical trials on Implanted Reactiv8 unit that is being ...
Singapore: International investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a ...
